Full Text View
Tabular View
No Study Results Posted
Related Studies
Short-Term Renal Hemodynamic Effects of Tolvaptan in Subjects With Autosomal Dominant Polycystic Kidney Disease (ADPKD)
This study has been completed.
Study NCT01336972   Information provided by Otsuka Pharmaceutical Development & Commercialization, Inc.

First Received on April 15, 2011.   Last Updated on December 5, 2012   History of Changes
Related Studies can be found by searching for the Conditions, Interventions, and Sponsors found in this study:
Additional conditions recognized in this trial
Kidney Diseases
Polycystic Kidney Diseases
Polycystic Kidney, Autosomal Dominant
More general conditions related to this trial
Kidney Diseases, Cystic
Urologic Diseases
Interventions listed in this trial
tolvaptan
Sponsors listed in this trial
Otsuka Pharmaceutical Development & Commercialization, Inc.


Contact Help Desk
Lister Hill National Center for Biomedical Communications,  U.S. National Library of Medicine,
U.S. National Institutes of Health,  U.S. Department of Health & Human Services,
USA.gov,  Copyright,  Privacy,  Accessibility,  Freedom of Information Act

U.S. National Institutes of Health U.S. National Library of Medicine U.S. Department of Health & Human Services